Alert detail

LCD L38582: MolDX: Molecular Testing for Solid Organ Allograft Rejection — CGS

Policy ID: LCD-L38582Specialty: TransplantationAdded: 6/5/2026Effective: July 10, 2025lcd
High

What changed

New molecular testing coverage impacts organ transplant billing.

Who’s affected: Transplantation billing teams · Effective: July 10, 2025

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 11 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

See audit packs — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Transplantation— the week’s changes and deadlines, delivered to your inbox. No account required.